Tirzepatide in PWS, HO and GNSO
The Effects of Tirzepatide in Young Adults With Prader-Willi Syndrome, Hypothalamic Obesity and General Non-Syndromic Obesity
Sponsor: Children's Hospitals and Clinics of Minnesota
This PHASE4 trial investigates Hypothalamic Obesity and Obesity/Therapy and is currently actively recruiting participants. Children's Hospitals and Clinics of Minnesota leads this study, which shows 3 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
3 versions recorded-
Oct 2025 — Present [monthly]
Recruiting PHASE4
-
Jun 2025 — Oct 2025 [monthly]
Recruiting PHASE4
-
Apr 2025 — Jun 2025 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospitals and Clinics of Minnesota
- Grace Kim
- Seattle Children's Hospital
- Vanderbilt University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .